Curevac Nv (NASDAQ: CVAC) reported Q4 2023 earnings per share (EPS) of -$0.43, up 40.11% year over year. Total Curevac Nv earnings for the quarter were -$96.28 million. In the same quarter last year, Curevac Nv's earnings per share (EPS) was -$0.72.
As of Q2 2024, Curevac Nv's earnings has grown year over year. Curevac Nv's earnings in the past year totalled -$279.75 million.
What is CVAC's earnings date?
Curevac Nv's earnings date is Invalid Date. Add CVAC to your watchlist to be reminded of CVAC's next earnings announcement.
What was CVAC's revenue last quarter?
Curevac Nv (NASDAQ: CVAC) reported Q4 2023 revenue of $25.07 million up 101.64% year over year. In the same quarter last year, Curevac Nv's revenue was $12.44 million.
What was CVAC's revenue growth in the past year?
As of Q2 2024, Curevac Nv's revenue has grown -16.72% year over year. This is 161.35 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Curevac Nv's revenue in the past year totalled $57.80 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.